January 27, 2022 Admin Press Releases OcyonBio Appoints Daniel Chang, CPA, MBA, CPMP, CPIM as Chief Financial Officer 0 Read More
January 20, 2022 Admin Blog Articles Partnership Development Management Organization(PDMO) – CDMO alternative for Gene and Cell Therapy, Virus and Biologics Mfg. 1 Read More
January 20, 2022 Admin Blog Articles Donor Derived Supply Clift Risk(s)- Gene and Cell Therapy Companies 0 Read More
January 20, 2022 Admin Blog Articles, Uncategorized OCYONBIO cGMP space and Viral Manufacturing Capabilities Ready to Go ! 0 Read More
January 20, 2022 Admin Blog Articles Non-Dilutive Funding driven by Business Incentive Office (BIO) by OCYONBIO 0 Read More
January 19, 2022 Admin Press Releases Health Tech: Robert Salcedo On How OcyonBio’s Technology Can Make An Important Impact On Our Overall Wellness 1 Read More
January 19, 2022 Admin Press Releases OcyonBio Appoints Robert Salcedo as Chief Executive Officer 0 Read More
March 17, 2021 Admin Press Releases Biosimilar Solutions, Inc. enters License and Development Agreement with Reliance Life Sciences Ltd 0 Read More
February 3, 2021 Admin Press Releases Invest Puerto Rico elevates the Island’s role as a global bioscience R&D and manufacturing hub attracting two major life-critical investments, $228M in new activity 0 Read More